New cancer clinical trial: Non-Interventional Study in Patients With Relapsed or Refractory Mantle Cell Lymphoma (R/R MCL) to Investigate the Association of Lenalidomide With Tumor Flare Reaction and High Tumor Burden

Published on: August 27, 2018 at 12:00PM
Condition:   Lymphoma, Mantle-Cell
Intervention:   Drug: Lenalidomide
Sponsor:   Celgene
Not yet recruiting
https://ift.tt/2NqlQKL